Clinical Trial Update: Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome

View source ↗

Summary

A completed clinical trial investigating the resolution of the primary immune defect in individuals with 22q11.2 deletion syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome
• Immunodeficiency

Snippet

Sponsor: Mahidol University | Conditions: Immune Defect, 22q11.2 Deletion Syndrome | Status: COMPLETED